Software for gut health and probiotic brands

Gut health is one of the strongest growth stories in the EU supplement market, and probiotics sit at its centre — with a set of formulation problems shared by no other category. The actives are living organisms measured in CFU, they lose viability over shelf life, and the headline word "probiotic" is treated in most of the EU as an unauthorized health claim. Formulating here means solving a microbiology problem and a claims problem at once. Here is where software is essential.

CFU is the dose, and it decays

A probiotic's dose is colony-forming units, not milligrams, and unlike a vitamin, a live culture declines from the moment it is made. The label promises a CFU count at end of shelf life, but the product has to be made with more — a deliberate overage that accounts for predictable die-off through production and storage. Software that separates the input CFU from the end-of-life label claim makes that overage an explicit, documented number per strain, rather than a guess that either wastes expensive culture or risks an under-strength product at expiry.

Strains are the real ingredients

"Lactobacillus" means little; the specific strain means everything — for the science, the documentation, and any future claim. Serious probiotic formulation records the product at strain level, with each strain's identity, CFU contribution and supplier data held as real ingredient information. A multi-strain blend is then a sum of precisely specified organisms, and the total CFU, the per-strain breakdown and the cost all compute from the strain data.

The claims problem is the category's defining constraint

In most of the EU, "probiotic" is considered a health claim and is not authorized for use, so brands navigate a careful line — describing strains, declaring CFU, and relying on authorized claims (often a vitamin or mineral added precisely for this purpose) to say anything about benefit. Linking claims to their status at the formula level keeps the brand inside what is permitted and flags the difference between what it wants to say and what it may.

Stability is a shelf-life promise you have to back

The CFU overage assumes a die-off curve, and that curve has to be supported by stability data for the specific strains, format and packaging. Keeping the stability rationale attached to the formula ties the end-of-life claim to the evidence behind it — the documentation a retailer or auditor expects from a serious probiotic product.

Formats add their own decay

Probiotics appear in capsules, sachets, gummies and drinks, and each format stresses the organisms differently — heat, moisture, water activity. The overage and the format are linked, so modelling them together keeps the CFU promise honest across the range.

Because the rules around probiotic claims and the term "probiotic" differ by market and are evolving, confirm the current EU requirements for your specific products rather than relying on a general summary.

Where Lemoniq fits

Lemoniq models probiotics at strain level, separates input CFU from end-of-life claims so overage is explicit, links claims to their regulatory status, and keeps stability rationale attached to the formula — across every format. The microbiology and the claims discipline live in one record.

The takeaway

Probiotics combine a decaying live-organism dose with the EU's tightest naming constraints. The brands that win gut health are the ones whose software handles CFU overage, strain-level data and claim status together — because doing any of them by hand is where the category goes wrong.

Lemoniq manages CFU overage, strain data and claim status for probiotic brands in one platform. We solve this exact problem. See how it works